Karen L. Parkhill - 29 Jul 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 17:22:35 UTC
Previous filing
05 May 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Disposed to Issuer $0 -15,151 -43% $0.000000 20,218 29 Jul 2022 Direct F1, F2
holding MDT Ordinary Shares 49,859 29 Jul 2022 Jeffrey S. Parkhill 2021 Irrevocable Trust F3
holding MDT Ordinary Shares 843 29 Jul 2022 By Child #1
holding MDT Ordinary Shares 843 29 Jul 2022 By Child #2
holding MDT Ordinary Shares 843 29 Jul 2022 By Child #3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target.
F2 This balance increased by 423 shares due to exempt acquisitions through dividend reinvestment.
F3 These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.